MHMeghan E. Hurley

Meghan E. Hurley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meghan E. Hurley has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Impact of personalized risk communication on patient understanding and decision-making in LVAD therapy

    by Kristin Kostick-Quenet, Rita Dexter, Jared N. Smith, Meghan E. Hurley, Joanna Smolenski, Andrew Civitello, Lola Xie, Nir Uriel, Pavan Bhat, Michael Givertz, et al.

  • Open Access

    Perceived Sensitivity of Sensor-Based Digital Health Data: Qualitative Interview Study

    by Christine Deeney, Anika Sonig, Meghan E Hurley, Birkan Tunç, Eric A Storch, John D Herrington, Jennifer Blumenthal-Barby, Kristin Kostick-Quenet

    Background: Digital health tools are increasingly used in mental health care to passively collect patient data and analyze health status outside of clinical settings. While technologies such as digital phenotyping, affective computing, and computational behavioral analysis offer new insights into symptom manifestation in daily life, they generate large volumes of potentially sensitive data that raise significant data privacy concerns, requiring high levels of patient awareness and consent. Empirical research is lacking on stakeholder understandings toward the sensitivity of these data and expectations for data stewardship, perspectives that are critical for developing robust informed consent and data protection policies for digital health data use. Objective: This study aimed to explore key stakeholder perspectives on the sensitivity of computer perception (CP) data, trust in existing data protections, willingness to share CP data externally, and desire for transparency of CP data transactions outside of the clinical space. Methods: As part of a larger, multisite study, we conducted qualitative interviews (n=40) via Zoom (Zoom Communications, Inc) with 20 adolescents (aged 12‐17 years) familiar with CP tools and their caregivers (n=20). Interviews consisted of a series of open-ended questions regarding stakeholders’ perspectives on privacy, data security, and the use and exchange of CP data. We developed a qualitative codebook to identify and label thematic patterns in responses to questions addressing the topics above, using thematic content analysis to identify themes inductively. Each interview was coded by merging work from at least two separate coders, and several team members contributed to qualitative analysis. Results: Most adolescents and caregivers viewed CP data as highly sensitive and expressed a reluctance to share these data beyond their clinical teams. While many participants expressed trust in existing data protections to protect CP data, they often misunderstood or overestimated the extent of protections to safeguard CP data. Conclusions: Our findings underscore the critical need for clear and effective patient communication and education about the risks, benefits, and protections associated with CP data through informed consent protocols. To promote greater transparency, understanding, and trust, we recommend 5 strategies: educating patients about data protection; studying secondary data exchange and reidentification risks; strengthening transparency regulations; improving data traceability mechanisms, such as distributed ledger technologies, to enhance data traceability and auditability; and adopting dynamic consent models.

  • In Algorithms We Trust? Stakeholder Perspectives on Algorithmic and AI-Based Survival Calculators

    by Meghan E. Hurley, Kristin Kostick-Quenet, Jared N. Smith, Joanna Smolenski, Rita Dexter, Jennifer Blumenthal-Barby

  • Open Access

    Stakeholder Perspectives on Humanistic Implementation of Computer Perception in Health Care: Qualitative Study

    by Kristin M Kostick-Quenet, Meghan E Hurley, Syed Ayaz, John D Herrington, Casey J Zampella, Julia Parish-Morris, Birkan Tunç, Gabriel Lázaro-Muñoz, Jennifer Blumenthal-Barby, Eric A Storch

    Background: Computer perception (CP) technologies—including digital phenotyping, affective computing, and related passive sensing approaches—offer unprecedented opportunities to personalize health care, especially mental health care, yet they also provoke concerns about privacy, bias, and the erosion of empathic, relationship-centered practice. At present, it remains elusive what stakeholders who design, deploy, and experience these tools in real-world settings perceive as the risks and benefits of CP technologies. Objective: This study aims to explore key stakeholder perspectives on the potential benefits, risks, and concerns associated with integrating CP technologies into patient care. A better understanding of these concerns is crucial for responding to and mitigating such concerns via design implementation strategies that augment, rather than compromise, patient-centered and humanistic care and associated outcomes. Methods: We conducted in-depth, semistructured interviews with 102 stakeholders involved at key points in CP’s development and implementation: adolescent patients (n=20) and their caregivers (n=20); frontline clinicians (n=20); technology developers (n=21); and ethics, legal, policy, or philosophy scholars (n=21). Interviews (~ 45 minutes each) explored perceived benefits, risks, and implementation challenges of CP in clinical care. Transcripts underwent thematic analysis by a multidisciplinary team; reliability was enhanced through double coding and consensus adjudication. Results: Stakeholders raised concerns across 7 themes: (1) Data Privacy and Protection (88/102, 86.3%); (2) Trustworthiness and Integrity of CP Technologies (72/102, 70.6%); (3) direct and indirect Patient Harms (65/102, 63.7%); (4) Utility and Implementation Challenges (60/102, 58.8%); (5) Patient-Specific Relevance (24/102, 23.5%); (6) Regulation and Governance (17/102, 16.7%); and (7) Philosophical Critiques of reductionism (13/102, 12.7%). A cross-cutting insight was the primacy of context and subjective meaning in determining whether CP outputs are clinically valid and actionable. Participants warned that without attention to these factors, algorithms risk misclassification and dehumanization of care. Conclusions: To operationalize humanistic safeguards, we propose “personalized road maps”: co-designed plans that predetermine which metrics will be monitored, how and when feedback is shared, thresholds for clinical action, and procedures for reconciling discrepancies between algorithmic inferences and lived experience. Road maps embed patient education, dynamic consent, and tailored feedback, thereby aligning CP deployment with patient autonomy, therapeutic alliance, and ethical transparency. This multistakeholder study provides the first comprehensive, evidence-based account of relational, technical, and governance challenges raised by CP tools in clinical care. By translating these insights into personalized road maps, we offer a practical framework for developers, clinicians, and policy makers seeking to harness continuous behavioral data while preserving the humanistic core of care.


  • Open Access

    Stakeholder Criteria for Trust in Artificial Intelligence–Based Computer Perception Tools in Health Care: Qualitative Interview Study

    by Ansh Rai, Meghan E Hurley, John Herrington, Eric A Storch, Casey J Zampella, Julia Parrish-Morris, Anika Sonig, Gabriel LázAro-MuñoZ, Kristin Kostick-Quenet

    Background: Computer perception (CP) technologies hold significant promise for advancing precision mental health care systems, given their ability to leverage algorithmic analysis of continuous, passive sensing data from wearables and smartphones (eg, behavioral activity, geolocation, vocal features, and ambient environmental data) to infer clinically meaningful behavioral and physiological states. However, successful implementation critically depends on cultivating well-founded stakeholder trust. Objective: This study aims to investigate, across adolescents, caregivers, clinicians, and developers, the contingencies under which CP technologies are deemed trustworthy in health care. Methods: We conducted 80 semistructured interviews with a purposive sample of adolescents (n=20) diagnosed with autism, Tourette syndrome, anxiety, obsessive-compulsive disorder, or attention-deficit/hyperactivity disorder and their caregivers (n=20); practicing clinicians across psychiatry, psychology, and pediatrics (n=20); and CP system developers (n=20). Interview transcripts were coded by 2 independent coders and analyzed using multistage, inductive thematic content analysis to identify prominent themes. Results: Across stakeholder groups, 5 core criteria emerged as prerequisites for trust in CP outputs: (1) epistemic alignment—consistency between system outputs, personal experience, and existing diagnostic frameworks; (2) demonstrable rigor—training on representative data and validation in real-world contexts; (3) explainability—transparent communication of input variables, thresholds, and decision logic; (4) sensitivity to complexity—the capacity to accommodate heterogeneity and comorbidity in symptom expression; and (5) a nonsubstitutive role—technologies must augment, rather than supplant, clinical judgment. A novel and cautionary finding was that epistemic alignment—whether outputs affirmed participants’ preexisting beliefs, diagnostic expectations, or internal states—was a dominant factor in determining whether the tool was perceived as trustworthy. Participants also expressed relational trust, placing confidence in CP systems based on endorsements from respected peers, academic institutions, or regulatory agencies. However, both trust strategies raise significant concerns: confirmation bias may lead users to overvalue outputs that align with their assumptions, while surrogate trust may be misapplied in the absence of robust performance validation. Conclusions: This study advances empirical understanding of how trust is formed and calibrated around artificial intelligence–based CP technologies. While trust is commonly framed as a function of technical performance, our findings show that it is deeply shaped by cognitive heuristics, social relationships, and alignment with entrenched epistemologies. These dynamics can facilitate intuitive verification but may also constrain the transformative potential of CP systems by reinforcing existing beliefs. To address this, we recommend a dual strategy: (1) embedding CP tools within institutional frameworks that uphold rigorous validation, ethical oversight, and transparent design; and (2) providing clinicians with training and interface designs that support critical appraisal and minimize susceptibility to cognitive bias. Recalibrating trust to reflect actual system capacities—rather than familiarity or endorsement—is essential for ethically sound and clinically meaningful integration of CP technologies.


  • Open Access

    Stakeholder Perspectives on Humanistic Implementation of Computer Perception in Health Care: Qualitative Study (Preprint)

    by Kristin M Kostick-Quenet, Meghan E Hurley, Syed Ayaz, John D Herrington, Casey J Zampella, Julia Parish-Morris, Birkan Tunç, Gabriel Lázaro-Muñoz, Jennifer Blumenthal-Barby, Eric A Storch

    BACKGROUND Computer perception (CP) technologies—including digital phenotyping, affective computing, and related passive sensing approaches—offer unprecedented opportunities to personalize health care, especially mental health care, yet they also provoke concerns about privacy, bias, and the erosion of empathic, relationship-centered practice. At present, it remains elusive what stakeholders who design, deploy, and experience these tools in real-world settings perceive as the risks and benefits of CP technologies. OBJECTIVE This study aims to explore key stakeholder perspectives on the potential benefits, risks, and concerns associated with integrating CP technologies into patient care. A better understanding of these concerns is crucial for responding to and mitigating such concerns via design implementation strategies that augment, rather than compromise, patient-centered and humanistic care and associated outcomes. METHODS We conducted in-depth, semistructured interviews with 102 stakeholders involved at key points in CP’s development and implementation: adolescent patients (n=20) and their caregivers (n=20); frontline clinicians (n=20); technology developers (n=21); and ethics, legal, policy, or philosophy scholars (n=21). Interviews (~ 45 minutes each) explored perceived benefits, risks, and implementation challenges of CP in clinical care. Transcripts underwent thematic analysis by a multidisciplinary team; reliability was enhanced through double coding and consensus adjudication. RESULTS Stakeholders raised concerns across 7 themes: (1) Data Privacy and Protection (88/102, 86.3%); (2) Trustworthiness and Integrity of CP Technologies (72/102, 70.6%); (3) direct and indirect Patient Harms (65/102, 63.7%); (4) Utility and Implementation Challenges (60/102, 58.8%); (5) Patient-Specific Relevance (24/102, 23.5%); (6) Regulation and Governance (17/102, 16.7%); and (7) Philosophical Critiques of reductionism (13/102, 12.7%). A cross-cutting insight was the primacy of context and subjective meaning in determining whether CP outputs are clinically valid and actionable. Participants warned that without attention to these factors, algorithms risk misclassification and dehumanization of care. CONCLUSIONS To operationalize humanistic safeguards, we propose “personalized road maps”: co-designed plans that predetermine which metrics will be monitored, how and when feedback is shared, thresholds for clinical action, and procedures for reconciling discrepancies between algorithmic inferences and lived experience. Road maps embed patient education, dynamic consent, and tailored feedback, thereby aligning CP deployment with patient autonomy, therapeutic alliance, and ethical transparency. This multistakeholder study provides the first comprehensive, evidence-based account of relational, technical, and governance challenges raised by CP tools in clinical care. By translating these insights into personalized road maps, we offer a practical framework for developers, clinicians, and policy makers seeking to harness continuous behavioral data while preserving the humanistic core of care.

  • Open Access

    Stakeholder Criteria for Trust in Artificial Intelligence–Based Computer Perception Tools in Health Care: Qualitative Interview Study (Preprint)

    by Ansh Rai, Meghan E Hurley, John Herrington, Eric A Storch, Casey J Zampella, Julia Parrish-Morris, Anika Sonig, Gabriel LázAro-MuñoZ, Kristin Kostick-Quenet

    BACKGROUND Computer perception (CP) technologies hold significant promise for advancing precision mental health care systems, given their ability to leverage algorithmic analysis of continuous, passive sensing data from wearables and smartphones (eg, behavioral activity, geolocation, vocal features, and ambient environmental data) to infer clinically meaningful behavioral and physiological states. However, successful implementation critically depends on cultivating well-founded stakeholder trust. OBJECTIVE This study aims to investigate, across adolescents, caregivers, clinicians, and developers, the contingencies under which CP technologies are deemed trustworthy in health care. METHODS We conducted 80 semistructured interviews with a purposive sample of adolescents (n=20) diagnosed with autism, Tourette syndrome, anxiety, obsessive-compulsive disorder, or attention-deficit/hyperactivity disorder and their caregivers (n=20); practicing clinicians across psychiatry, psychology, and pediatrics (n=20); and CP system developers (n=20). Interview transcripts were coded by 2 independent coders and analyzed using multistage, inductive thematic content analysis to identify prominent themes. RESULTS Across stakeholder groups, 5 core criteria emerged as prerequisites for trust in CP outputs: (1) epistemic alignment—consistency between system outputs, personal experience, and existing diagnostic frameworks; (2) demonstrable rigor—training on representative data and validation in real-world contexts; (3) explainability—transparent communication of input variables, thresholds, and decision logic; (4) sensitivity to complexity—the capacity to accommodate heterogeneity and comorbidity in symptom expression; and (5) a nonsubstitutive role—technologies must augment, rather than supplant, clinical judgment. A novel and cautionary finding was that epistemic alignment—whether outputs affirmed participants’ preexisting beliefs, diagnostic expectations, or internal states—was a dominant factor in determining whether the tool was perceived as trustworthy. Participants also expressed relational trust, placing confidence in CP systems based on endorsements from respected peers, academic institutions, or regulatory agencies. However, both trust strategies raise significant concerns: confirmation bias may lead users to overvalue outputs that align with their assumptions, while surrogate trust may be misapplied in the absence of robust performance validation. CONCLUSIONS This study advances empirical understanding of how trust is formed and calibrated around artificial intelligence–based CP technologies. While trust is commonly framed as a function of technical performance, our findings show that it is deeply shaped by cognitive heuristics, social relationships, and alignment with entrenched epistemologies. These dynamics can facilitate intuitive verification but may also constrain the transformative potential of CP systems by reinforcing existing beliefs. To address this, we recommend a dual strategy: (1) embedding CP tools within institutional frameworks that uphold rigorous validation, ethical oversight, and transparent design; and (2) providing clinicians with training and interface designs that support critical appraisal and minimize susceptibility to cognitive bias. Recalibrating trust to reflect actual system capacities—rather than familiarity or endorsement—is essential for ethically sound and clinically meaningful integration of CP technologies.

  • Open Access

    Stakeholder Perspectives on Trust and Transparency around Digital Health Data: A Qualitative Interview Study (Preprint)

    by Christine Deeney, Anika Sonig, Meghan E Hurley, Birkan Tunç, Eric A Storch, John D Herrington, Jennifer Blumenthal-Barby, Kristin Kostick-Quenet

    BACKGROUND The integration of digital health tools and algorithms in mental healthcare brings a transformative era where technologies like digital phenotyping, affective computing, and computational behavioral analysis are used to passively collect and analyze data from patients outside clinical settings. These "computer perception" (CP) technologies offer new insights into symptom manifestation in daily life while generating large volumes of potentially sensitive data that raise significant data privacy concerns requiring high levels of patient awareness and consent. Empirical research is lacking into stakeholder understandings and perspective towards the collection, management and protection of these data types. OBJECTIVE This study aimed to explore key stakeholder perspectives on the sensitivity of CP data, trust in existing data protections, willingness to share CP data externally, and desire for transparency of CP data transactions outside of the clinical space. METHODS As part of a larger, multi-site study, we conducted qualitative interviews (n=40) via Zoom with 20 adolescents (aged 12-17 years) familiar with CP tools and their caregivers (n=20). Interviews consisted of a series of open-ended questions regarding stakeholders’ perspectives on privacy, data security, and the use and exchange of CP data. We developed a qualitative codebook to identify and label thematic patterns in responses to questions addressing the topics above, using thematic content analysis to inductively identify themes. Each interview was coded by merging work from at least two separate coders, and several team members contributed to qualitative analysis. RESULTS Most adolescents and caregivers viewed CP data as highly sensitive and expressed a reluctance to share these data beyond their clinical teams. While many participants expressed trust in existing data protections to protect CP data, they often misunderstood or overestimated the extent of protections like HIPAA to safeguard CP data. CONCLUSIONS Our findings underscore the critical need for clear and effective patient communication and education about the risks, benefits, and protections associated with CP data through informed consent protocols. To promote greater visibility, understanding, and trust (when justified) in digital tools that have strong promise to promote patient health, we recommend five key strategies, including: (1) educating patients on the limitations of existing data protections; (2) conducting targeted research, including forensic analyses, into secondary data exchanges and to identify privacy breaches or reidentification risks; (3) enacting regulations that mandate greater transparency in health data transactions; (4) implementing computational mechanisms, such as distributed ledger technologies, to enhance data traceability and auditability; and (5) adopting dynamic consent models that allow patients to continuously manage and update their consent preferences.


  • Open Access

    Should Physicians Take the Rap? Normative Analysis of Clinician Perspectives on Responsible Use of ‘Black Box’ AI Tools

    by Ben H. Lang, Kristin Kostick-Quenet, Jared N. Smith, Meghan Hurley, Rita Dexter, Jennifer Blumenthal-Barby

    Increasing interest in deploying artificial intelligence tools in clinical contexts has raised several ethical questions of both normative and empirical interest. One such question in the literature is whether "responsibility gaps" (r-gaps) are created when clinicians utilize or rely on such tools for providing care, and if so, what to do about them. These gaps are particularly likely to arise when using opaque, "black box" AI tools. Compared to normative and legal analysis of AI-generated responsibility gaps in health care, little is known, empirically, about health care providers views on this issue. The present study examines clinician perspectives on this issue in the context of black box AI decisional support systems (BBAI-DSS) in advanced heart failure. Semi-structured interviews were conducted with 20 clinicians (14 cardiologists and 6 LVAD nurse coordinators). Interviews were transcribed, coded, and thematically analyzed for salient themes. All study procedures were approved by local IRB. We found that all clinicians voiced that, if someone were responsible for the use and outcomes of black box AI, it would be physicians. We compare clinician perspectives on the existence of r-gaps and their impact on responsibility for errors or adverse outcomes when BBAI-DSS tools are used against a taxonomy from the literature, finding some clinicians acknowledging an r-gap and others denying it or its relevance in medical decision-making. Clinicians varied in their view about the existence of r-gaps but were united in their ascriptions of physician responsibility for the use of BBAI-DSS in clinical care. It was unclear at times whether these were descriptive or normative judgments (i.e., is it merely inevitable physicians will be responsible, or is it morally appropriate that they be held responsible?) or both. We discuss the likely normative inadequacy of such a conception of physician responsibility for BBAI tool use.